Coeliac disease and dermatitis herpetiformis are gluten dependent disorders. Both have a gluten sensitive enteropathy but the distinguishing feature between the two is a characteristic skin rash in dermatitis herpetiformis. In both conditions the lesions heal with a gluten free diet and recur on reintroduction of gluten.1 2 Previous reports of HLA associations have shown that patients with coeliac disease and dermatitis herpetiformis have similar sivnificant increases in the incidence of both HLA-B& 6 and HLA-DR3 7 in different population groups. These data have suggested that disease susceptibility gene(s) for both conditions are closely linked to HLA-B8-DR3. Because one group of patients only develops an enteropathy and the other skin lesions with mild enteropathy, however, there may be different genes playing a role in the manifestation of the disease in the two groups.
In addition to the HLA-DR series a second serologically defined series of HLA class II antigens, the DO series, was officially recognised at the 9th Histocompatibility Workshoplb after which 2  2  2  2  2  2  2  2  2  2  2  2  2  2  2  2   3  3  3  3  3  3  3  3  3  3  3  3  3   3  3  3  3   3  3  3  2 3  2 3 Nt=not tested, *=not tested for DQw2, <=less than. na=not available.
The minimal criteria for the diagnosis of coeliac disease were based on biopsies showing subtotal villous atrophy of the jejunal mucosa on a gluten containing diet followed by a clinical remission on a gluten free diet. The (Table 4) . These antigens were also present at significantly increased frequencies in the dermatitis herpetiformis patient group compared with controls. Al was present in 71%0 (p<0.0005), B8 in 75% (p<000()5) and Cw7 in 75% (p<0.0005) ( Table 4) .
BIOPSY REPORTS ON DR2 POSITIVE COEILIAC DISEASE 
PATIENTS
To determine whether coeliac disease patients who are DR2 had a less severe enteropathy, jejunal biopsies taken from four of the five patients after presentation and before introduction of a gluten free diet were reviewed. In two cases, the dissecting microscope appearance showed the mucosa to be flat and the other two as only convoluted. The severity of coeliac disease, however, also depends on the length of small intestine affected and a single biopsy taken from the proximal intestine would not necessarily reflect the extent of pathology.
Discussion
In addition to confirming the previously reported associations between dermatitis herpetiformis and DR3, this study shows for the first time a significant increase in the frequency of DR2 in dermatitis herpetiformis patients when compared with the control group. A non-significant increased frequency of DR2 in Austrian patients (38%0) compared with controls (25%) has been previously reported.13
The increase of DR2 in dermatitis herpetiformis compared with the control group is no longer significant when the p value is corrected-that is, multiplied by the number of antigens involved in the analysis, a standard procedure to exclude the possibility of a chance finding with so many variables. Because of the profound increase of DR3 in the same group of patients, however, there should be a proportionate compensatory decrease in the frequency of non-involved antigens, as indeed there is for DRI and DR4. Further support for the belief that the increased frequency of DR2 is real in dermatitis herpetiformis is underlined by the fact that the increase in frequency of DR2 in dermatitis herpetiformis is significant when compared with coeliac disease after correcting the p value.
The increased frequencies in coeliac disease of Al, B8, DR3, and DR7 confirm the findings of several other groups. Although the high frequency of DQw2 has been previously reported, ' Current investigations using HLA class II cDNA probes may disclose differences and/or similarities between the DR3 and DQw2 genes in healthy individuals and in patients with coeliac disease, dermatitis herpetiformis and other DR3 associated disorders.
The pathogenesis of both dermatitis herpetiformis and coeliac disease involve gluten intolerance and it is tempting to speculate that a disease susceptibility gene associated with DR3 is the same in both diseases and is responsible for the gluten intolerance. In coeliac disease a DR7 associated susceptibility gene may localise the pathology to the small intestine and a DR2 associated susceptibility gene in dermatitis herpetiformis may protect against the severe enteropathy found in coeliac disease, as suggested by Scholz and Albert,'5 with the result that there is a milder enteropathy which may allow a gluten diet to be tolerated leading later to skin involvement. It could be suggested, however, that the DR2 susceptibility gene not only has a protective effect on the small intestine but also predisposes to the development of the skin lesions found in dermatitis herpetiformis, thus accounting for the different clinical features found in coeliac disease and dermatitis herpetiformis. 
